{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:04:31Z","timestamp":1780452271623,"version":"3.54.1"},"reference-count":66,"publisher":"American Association of Psychiatric Pharmacists (AAPP)","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Emerging real-world evidence suggests that folate supplementation may reduce suicidal ideation and behavior. We conducted a scoping review to evaluate current hypothesis-testing literature on folate supplementation and outcomes related to suicide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched PubMed, Cochrane Library, APA PsycNet, ClinicalTrials.gov, and the International Clinical Trials Registry Platform from inception to February 15, 2025, to identify hypothesis-testing studies (ie, randomized, cohort, or case-control studies) that examined any oral folate formulation and reported a suicide-related endpoint.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Five studies met inclusion criteria: 1 randomized controlled trial (n = 475), 2 case-control studies (n &lt; 20 each), and 2 large within-person cohort analyses (&gt;800 000 adults). Interventions included folic acid 1 to 5 mg\/day (3 studies) or folinic acid 1 to 2 mg\/kg\/day (2 studies). Three studies reported significant reductions in suicidal outcomes. One within-person cohort study found a 44% lower hazard of suicide-related emergency or hospital visits after treatment with folic acid (hazard ratio = 0.56) (and none in a parallel analysis of vitamin B12). A second within-person stratified reanalysis showed benefit in both patients with and without psychiatric histories. One case-control study of patients with a history of suicidal behavior and ideation found lower suicidal ideation questionnaire scores with folinic acid (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.01). The randomized controlled trial and the other case-control study reported no significant benefit for suicide-related endpoints.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Evidence linking folate supplementation to reduced suicidal behavior is promising but limited by heterogeneity in design, sample size, folate formulation, and outcome measurement. Robust conclusions await large, pragmatic trials or extended real-world studies that integrate both suicidal behavior and mortality while comparing folate across diverse populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.9740\/mhc.2026.06.150","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:42:05Z","timestamp":1780364525000},"page":"150-158","source":"Crossref","is-referenced-by-count":0,"title":["The relationship between vitamin B9 (folate) supplementation and suicidality: a scoping review"],"prefix":"10.9740","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8882-1094","authenticated-orcid":true,"given":"Chris","family":"Noel","sequence":"first","affiliation":[{"name":"(Corresponding author) Associate Professor, Wegmans School of Pharmacy, St John Fisher University, Rochester, New York, cnoel@sjfc.edu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3825-5081","authenticated-orcid":true,"given":"Nick","family":"Lombardi","sequence":"additional","affiliation":[{"name":"Wegmans School of Pharmacy, St John Fisher University, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3270-3187","authenticated-orcid":true,"given":"Michelle","family":"Price","sequence":"additional","affiliation":[{"name":"Wegmans School of Pharmacy, St John Fisher University, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0595-3796","authenticated-orcid":true,"given":"Erik","family":"Herbert","sequence":"additional","affiliation":[{"name":"Wegmans School of Pharmacy, St John Fisher University, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3325-7510","authenticated-orcid":true,"given":"Jill E.","family":"Lavigne","sequence":"additional","affiliation":[{"name":"Professor Wegmans School of Pharmacy, St John Fisher University, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4719","reference":[{"key":"i2168-9709-16-3-150-b01","article-title":"Suicide data and statistics","author":"Centers for Disease Control and Prevention","year":"2025","unstructured":"Centers for Disease Control and Prevention. Suicide data and statistics. Suicide prevention [Internet]. Bethesda: Department of Health and Human Services; 2025 [cited 2025 Jul 2]. Available from: https:\/\/www.cdc.gov\/suicide\/facts\/data.html"},{"key":"i2168-9709-16-3-150-b02","article-title":"The re-emerging suicide crisis in the U.S.: patterns, causes and solutions","author":"Marcotte","year":"2023","unstructured":"Marcotte DE,\nHansen B. The re-emerging suicide crisis in the U.S.: patterns, causes and solutions. NBER Working Paper No. 31242 [Internet]. Cambridge: National Bureau of Economic Research; 2023 [cited 2025 Jul 2]. Available from: https:\/\/www.nber.org\/system\/files\/working_papers\/w31242\/w31242.pdf"},{"key":"i2168-9709-16-3-150-b03","article-title":"VA\/DoD clinical practice guideline for the assessment and management of patients at risk for suicide [Internet]","author":"Department of Veterans Affairs, Department of Defense","year":"2024","unstructured":"Department of Veterans Affairs, Department of Defense. VA\/DoD clinical practice guideline for the assessment and management of patients at risk for suicide [Internet]. Washington: Department of Veterans Affairs; 2024 [2025 Dec 16]. Available from: https:\/\/www.healthquality.va.gov\/HEALTHQUALITY\/guidelines\/MH\/srb\/VADOD-CPG-Suicide-Risk-Full-CPG-2024_Final_508.pdf"},{"issue":"5","key":"i2168-9709-16-3-150-b04","series-title":"Am J Clin Nutr","article-title":"Folate status in the US population 20 y after the introduction of folic acid fortification","volume":"110","author":"Pfeiffer","year":"2019","unstructured":"Pfeiffer CM,\nSternberg MR,\nZhang M,\nFazili Z,\nStorandt RJ,\nCrider KS, et al. Folate status in the US population 20 y after the introduction of folic acid fortification. Am J Clin Nutr. 2019;110(5):1088-97. DOI: 10.1093\/ajcn\/nqz184"},{"issue":"11","key":"i2168-9709-16-3-150-b05","series-title":"Lancet Neurol","article-title":"Vitamin B12, folic acid, and the nervous system","volume":"5","author":"Reynolds","year":"2006","unstructured":"Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol. 2006;5(11):949-60. DOI: 10.1016\/S1474-4422(06)70598-1"},{"issue":"6","key":"i2168-9709-16-3-150-b06","series-title":"Biol Psychiatry","article-title":"Serotonin, folic acid, and uric acid metabolism in the diagnosis of neuropsychiatric disorders","volume":"13","author":"Brooks","year":"1978","unstructured":"Brooks SC,\nLinn JJ,\nDisney N. Serotonin, folic acid, and uric acid metabolism in the diagnosis of neuropsychiatric disorders. Biol Psychiatry. 1978;13(6):671-84. 737255"},{"key":"i2168-9709-16-3-150-b07","series-title":"OSF","article-title":"The Relationship Between Vitamin B9 (Folate) Supplementation and Suicidality: A Scoping Review","author":"Noel","year":"2023","unstructured":"Noel C,\nLombardi N,\nPrice M,\nHerbert E,\nLavigne JE. The Relationship Between Vitamin B9 (Folate) Supplementation and Suicidality: A Scoping Review. OSF. Published 2023. Accessed August 1, 2025. doi:10.17605\/OSF.IO\/TQ8N7"},{"key":"i2168-9709-16-3-150-b08","article-title":"PRISMA for scoping reviews (PRISMA-ScR) [Internet]","author":"PRISMA Statement","year":"2018","unstructured":"PRISMA Statement. PRISMA for scoping reviews (PRISMA-ScR) [Internet]. PRISMA Statement website. 2018 [cited 2025 Jul 2]. Available from: https:\/\/www.prisma-statement.org\/scoping"},{"key":"i2168-9709-16-3-150-b09","series-title":"J Clin Epidemiol","article-title":"PRESS peer review of electronic search strategies: 2015 guideline statement","volume":"75","author":"McGowan","year":"2016","unstructured":"McGowan J,\nSampson M,\nSalzwedel DM,\nCogo E,\nFoerster V,\nLefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40-6. DOI: 10.1016\/j.jclinepi.2016.01.021"},{"key":"i2168-9709-16-3-150-b10","series-title":"Syst Rev","first-page":"210","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","unstructured":"Ouzzani M,\nHammady H,\nFedorowicz Z,\nElmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev. 2016;5:210. DOI: 10.1186\/s13643-016-0384-4"},{"key":"i2168-9709-16-3-150-b11","article-title":"Study quality assessment tools [Internet]","author":"National Heart, Lung, and Blood Institute","year":"2021","unstructured":"National Heart, Lung, and Blood Institute. Study quality assessment tools [Internet]. Bethesda: National Institutes of Health; 2021 [cited 2025 Jul 2]. Available from: https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools"},{"issue":"48","key":"i2168-9709-16-3-150-b12","series-title":"Health Technol Assess","first-page":"1","article-title":"Folate augmentation of treatment\u2014evaluation for depression (FolATED): randomized trial and economic evaluation","volume":"18","author":"Bedson","year":"2014","unstructured":"Bedson E,\nBell D,\nCarr D,\nCarter B,\nHughes D,\nJorgensen A, et al. Folate augmentation of treatment\u2014evaluation for depression (FolATED): randomized trial and economic evaluation. Health Technol Assess. 2014;18(48):vii-viii, 1-159. doi:10.3310\/hta18480"},{"issue":"1","key":"i2168-9709-16-3-150-b13","series-title":"Am J Psychiatry","first-page":"42","article-title":"Neurometabolic disorders: potentially treatable abnormalities in patients with treatment-refractory depression and suicidal behavior","volume":"174","author":"Pan","year":"2017","unstructured":"Pan LA,\nMartin P,\nZimmer T,\nSegreti AM,\nKassiff S,\nMcKain BW, et al. Neurometabolic disorders: potentially treatable abnormalities in patients with treatment-refractory depression and suicidal behavior. Am J Psychiatry. 2017;174(1):42-50. DOI: 10.1176\/appi.ajp.2016.15111500"},{"issue":"13","key":"i2168-9709-16-3-150-b14","series-title":"Psychol Med","article-title":"Metabolomic disorders: confirmed presence of potentially treatable abnormalities in patients with treatment-refractory depression and suicidal behavior","volume":"53","author":"Pan","year":"2023","unstructured":"Pan LA,\nSegreti AM,\nWrobleski J,\nShaw A,\nHyland K,\nHughes M, et al. Metabolomic disorders: confirmed presence of potentially treatable abnormalities in patients with treatment-refractory depression and suicidal behavior. Psychol Med. 2023;53(13):6046-54. DOI: 10.1017\/S0033291722003233"},{"issue":"11","key":"i2168-9709-16-3-150-b15","series-title":"JAMA Psychiatry","article-title":"Association between folic acid prescription fills and suicide attempts and intentional self-harm among privately insured US adults","volume":"79","author":"Gibbons","year":"2022","unstructured":"Gibbons RD,\nHur K,\nLavigne JE,\nMann JJ. Association between folic acid prescription fills and suicide attempts and intentional self-harm among privately insured US adults. JAMA Psychiatry. 2022;79(11):1118-23. DOI: 10.1001\/jamapsychiatry.2022.2990"},{"issue":"5","key":"i2168-9709-16-3-150-b16","series-title":"BJPsych Open","first-page":"e159","article-title":"Folic acid prescription and suicide attempt prevention: effect of past suicidal behaviour, psychiatric diagnosis and psychotropic medication","volume":"9","author":"Mann","year":"2023","unstructured":"Mann JJ,\nHur K,\nLavigne JE,\nGibbons RD. Folic acid prescription and suicide attempt prevention: effect of past suicidal behaviour, psychiatric diagnosis and psychotropic medication. BJPsych Open. 2023;9(5):e159. DOI: 10.1192\/bjo.2023.549"},{"key":"i2168-9709-16-3-150-b17","article-title":"Mini-international neuropsychiatric interview, English version 5.0.0 (DSM-IV)","author":"Sheehan","year":"2006","unstructured":"Sheehan DV,\nJanavs J, et al. Mini-international neuropsychiatric interview, English version 5.0.0 (DSM-IV). Tampa, FL: University of South Florida; 2006."},{"key":"i2168-9709-16-3-150-b18","article-title":"Suicidal ideation questionnaire (SIQ) professional manual","author":"Reynolds","year":"1987","unstructured":"Reynolds WM. Suicidal ideation questionnaire (SIQ) professional manual. Assessment Resources; 1987."},{"issue":"5","key":"i2168-9709-16-3-150-b19","series-title":"JAMA","article-title":"US Preventive Services Task Force. Folic acid supplementation to prevent neural tube defects: US Preventive Services Task Force reaffirmation recommendation statement","volume":"330","author":"Barry","year":"2023","unstructured":"Barry MJ,\nNicholson WK,\nSilverstein M,\nChelmow D,\nCoker TR,\nDavis EM, et al.; US Preventive Services Task Force. Folic acid supplementation to prevent neural tube defects: US Preventive Services Task Force reaffirmation recommendation statement. JAMA. 2023;330(5):454-9. DOI: 10.1001\/jama.2023.1287637526713"},{"issue":"44","key":"i2168-9709-16-3-150-b20","series-title":"Federal Register","article-title":"Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid; final rule","volume":"61","author":"U.S. Food and Drug Administration","year":"1996","unstructured":"U.S. Food and Drug Administration. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid; final rule. Federal Register. 1996;61(44):8781-97."},{"key":"i2168-9709-16-3-150-b21","series-title":"Front Public Health","first-page":"550753","article-title":"Association between folate and health outcomes: an umbrella review of meta-analyses","volume":"8","author":"Bo","year":"2020","unstructured":"Bo Y,\nZhu Y,\nTao Y, et al. Association between folate and health outcomes: an umbrella review of meta-analyses. Front Public Health. 2020;8:550753. DOI: 10.3389\/fpubh.2020.550753"},{"issue":"3","key":"i2168-9709-16-3-150-b22","series-title":"Am J Psychiatry","article-title":"Folate, vitamin B12, and homocysteine in major depressive disorder","volume":"154","author":"Fava","year":"1997","unstructured":"Fava M,\nBorus JS,\nAlpert JE, et al. Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatry. 1997;154(3):426-8. DOI: 10.1176\/ajp.154.3.4269054796"},{"issue":"8","key":"i2168-9709-16-3-150-b23","series-title":"J Clin Psychiatry","article-title":"Serum folate, vitamin B12, and homocysteine in major depressive disorder, part 1: predictors of clinical response in fluoxetine-resistant depression","volume":"65","author":"Papakostas","year":"2004","unstructured":"Papakostas GI,\nPetersen T,\nMischoulon D,\nRyan JL,\nNierenberg AA,\nBottiglieri T, et al. Serum folate, vitamin B12, and homocysteine in major depressive disorder, part 1: predictors of clinical response in fluoxetine-resistant depression. J Clin Psychiatry. 2004;65(8):1090-5. DOI: 10.4088\/JCP.v65n0810"},{"issue":"8","key":"i2168-9709-16-3-150-b24","series-title":"J Clin Psychiatry","article-title":"Serum folate, vitamin B12, and homocysteine in major depressive disorder, part 2: predictors of relapse during the continuation phase of pharmacotherapy","volume":"65","author":"Papakostas","year":"2004","unstructured":"Papakostas GI,\nPetersen T,\nMischoulon D,\nGreen CH,\nNierenberg AA,\nBottigleri T, et al. Serum folate, vitamin B12, and homocysteine in major depressive disorder, part 2: predictors of relapse during the continuation phase of pharmacotherapy. J Clin Psychiatry. 2004;65(8):1096-8. DOI: 10.4088\/JCP.v65n0811"},{"issue":"12","key":"i2168-9709-16-3-150-b25","series-title":"Am J Psychiatry","article-title":"L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials","volume":"169","author":"Papakostas","year":"2012","unstructured":"Papakostas GI,\nShelton RC,\nZajecka JM,\nEtemad B,\nRickels K,\nClaim A, et al. L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. Am J Psychiatry. 2012;169(12):1267-74. DOI: 10.1176\/appi.ajp.2012.11071114"},{"key":"i2168-9709-16-3-150-b26","article-title":"Guidance for industry: suicidal ideation and behavior\u2014prospective assessment of occurrence in clinical trials [Internet]","author":"US Food and Drug Administration, Center for Drug Evaluation and Research","year":"2012","unstructured":"US Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for industry: suicidal ideation and behavior\u2014prospective assessment of occurrence in clinical trials [Internet]. Silver Spring, MD: FDA; 2012 [2025 Jul 2]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/guidance-industry-suicidal-ideation-and-behavior-prospective-assessment-occurrence-clinical-trials"},{"issue":"4","key":"i2168-9709-16-3-150-b27","series-title":"Arch Suicide Res","first-page":"287","article-title":"Predictive validity of the MINI suicidal scale for self-harm in acute psychiatry: a prospective study of the first year after discharge","volume":"16","author":"Roaldset","year":"2012","unstructured":"Roaldset JO,\nLinaker OM,\nBj\u00f8rkly S. Predictive validity of the MINI suicidal scale for self-harm in acute psychiatry: a prospective study of the first year after discharge. Arch Suicide Res. 2012;16(4):287-302. DOI: 10.1080\/13811118.2013.722052"},{"issue":"4","key":"i2168-9709-16-3-150-b28","series-title":"Evid Based Ment Health","article-title":"Risk factors for suicide in adults: systematic review and meta-analysis of psychological autopsy studies","volume":"25","author":"Favril","year":"2022","unstructured":"Favril L,\nYu R,\nUyar A,\nSharpe M,\nFazel S. Risk factors for suicide in adults: systematic review and meta-analysis of psychological autopsy studies. Evid Based Ment Health. 2022;25(4):148-55. doi:10.1136\/ebmental-2022-300549"},{"issue":"6","key":"i2168-9709-16-3-150-b29","series-title":"Aust N Z J Psychiatry","article-title":"Suicide mortality after a nonfatal suicide attempt: a systematic review and meta-analysis","volume":"56","author":"Demesmaeker","year":"2022","unstructured":"Demesmaeker A,\nChazard E,\nHoang A,\nVaiva G,\nAmad A. Suicide mortality after a nonfatal suicide attempt: a systematic review and meta-analysis. Aust N Z J Psychiatry. 2022;56(6):603-16. DOI: 10.1177\/00048674211043455"},{"issue":"1","key":"i2168-9709-16-3-150-b30","series-title":"Arch Gen Psychiatry","first-page":"82","article-title":"International Suicide Prevention Trial Study Group. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT)","volume":"60","author":"Meltzer","year":"2003","unstructured":"Meltzer HY,\nAlphs L,\nGreen AI,\nAltamura AC,\nAnand R,\nBertoldi A, et al.; International Suicide Prevention Trial Study Group. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry. 2003;60(1):82-91. DOI: 10.1001\/archpsyc.60.1.82"},{"issue":"2","key":"i2168-9709-16-3-150-b31","series-title":"Focus (Am Psychiatr Publ)","first-page":"197","article-title":"Pharmacological and somatic treatment effects on suicide in adults: a systematic review and meta-analysis","volume":"21","author":"Wilkinson","year":"2023","unstructured":"Wilkinson ST,\nTrujillo Diaz D,\nRupp ZW,\nKidambi A,\nRamirez KL,\nFlores JM, et al. Pharmacological and somatic treatment effects on suicide in adults: a systematic review and meta-analysis. Focus (Am Psychiatr Publ). 2023;21(2):197-208. DOI: 10.1176\/appi.focus.23021006"},{"key":"i2168-9709-16-3-150-b32","article-title":"Prepregnancy Counseling","author":"American College of Obstetricians and Gynecologists","year":"2019","unstructured":"American College of Obstetricians and Gynecologists. Prepregnancy Counseling. Committee Opinion No. 762 [Internet] Washington, DC: ACOG; 2019 [cited 2025 Jun 16]. Available from: https:\/\/www.acog.org\/clinical\/clinical-guidance\/committee-opinion\/articles\/2019\/01\/prepregnancy-counseling"},{"issue":"9","key":"i2168-9709-16-3-150-b33","series-title":"Can J Psychiatry","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 update on clinical guidelines for management of major depressive disorder in adults","volume":"69","author":"Lam","year":"2024","unstructured":"Lam RW,\nKennedy SH,\nAdams C,\nBahji A,\nBeaulieu S,\nBhat V,et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 update on clinical guidelines for management of major depressive disorder in adults. Can J Psychiatry. 2024;69(9):641-87. DOI: 10.1177\/07067437241245384"},{"key":"i2168-9709-16-3-150-b01","article-title":"Suicide data and statistics","author":"Centers for Disease Control and Prevention","year":"2025","unstructured":"Centers for Disease Control and Prevention. Suicide data and statistics. Suicide prevention [Internet]. Bethesda: Department of Health and Human Services; 2025 [cited 2025 Jul 2]. Available from: https:\/\/www.cdc.gov\/suicide\/facts\/data.html"},{"key":"i2168-9709-16-3-150-b02","article-title":"The re-emerging suicide crisis in the U.S.: patterns, causes and solutions","author":"Marcotte","year":"2023","unstructured":"Marcotte DE,\nHansen B. The re-emerging suicide crisis in the U.S.: patterns, causes and solutions. NBER Working Paper No. 31242 [Internet]. Cambridge: National Bureau of Economic Research; 2023 [cited 2025 Jul 2]. Available from: https:\/\/www.nber.org\/system\/files\/working_papers\/w31242\/w31242.pdf"},{"key":"i2168-9709-16-3-150-b03","article-title":"VA\/DoD clinical practice guideline for the assessment and management of patients at risk for suicide [Internet]","author":"Department of Veterans Affairs, Department of Defense","year":"2024","unstructured":"Department of Veterans Affairs, Department of Defense. VA\/DoD clinical practice guideline for the assessment and management of patients at risk for suicide [Internet]. Washington: Department of Veterans Affairs; 2024 [2025 Dec 16]. Available from: https:\/\/www.healthquality.va.gov\/HEALTHQUALITY\/guidelines\/MH\/srb\/VADOD-CPG-Suicide-Risk-Full-CPG-2024_Final_508.pdf"},{"issue":"5","key":"i2168-9709-16-3-150-b04","series-title":"Am J Clin Nutr","article-title":"Folate status in the US population 20 y after the introduction of folic acid fortification","volume":"110","author":"Pfeiffer","year":"2019","unstructured":"Pfeiffer CM,\nSternberg MR,\nZhang M,\nFazili Z,\nStorandt RJ,\nCrider KS, et al. Folate status in the US population 20 y after the introduction of folic acid fortification. Am J Clin Nutr. 2019;110(5):1088-97. DOI: 10.1093\/ajcn\/nqz184"},{"issue":"11","key":"i2168-9709-16-3-150-b05","series-title":"Lancet Neurol","article-title":"Vitamin B12, folic acid, and the nervous system","volume":"5","author":"Reynolds","year":"2006","unstructured":"Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol. 2006;5(11):949-60. DOI: 10.1016\/S1474-4422(06)70598-1"},{"issue":"6","key":"i2168-9709-16-3-150-b06","series-title":"Biol Psychiatry","article-title":"Serotonin, folic acid, and uric acid metabolism in the diagnosis of neuropsychiatric disorders","volume":"13","author":"Brooks","year":"1978","unstructured":"Brooks SC,\nLinn JJ,\nDisney N. Serotonin, folic acid, and uric acid metabolism in the diagnosis of neuropsychiatric disorders. Biol Psychiatry. 1978;13(6):671-84. 737255"},{"key":"i2168-9709-16-3-150-b07","series-title":"OSF","article-title":"The Relationship Between Vitamin B9 (Folate) Supplementation and Suicidality: A Scoping Review","author":"Noel","year":"2023","unstructured":"Noel C,\nLombardi N,\nPrice M,\nHerbert E,\nLavigne JE. The Relationship Between Vitamin B9 (Folate) Supplementation and Suicidality: A Scoping Review. OSF. Published 2023. Accessed August 1, 2025. doi:10.17605\/OSF.IO\/TQ8N7"},{"key":"i2168-9709-16-3-150-b08","article-title":"PRISMA for scoping reviews (PRISMA-ScR) [Internet]","author":"PRISMA Statement","year":"2018","unstructured":"PRISMA Statement. PRISMA for scoping reviews (PRISMA-ScR) [Internet]. PRISMA Statement website. 2018 [cited 2025 Jul 2]. Available from: https:\/\/www.prisma-statement.org\/scoping"},{"key":"i2168-9709-16-3-150-b09","series-title":"J Clin Epidemiol","article-title":"PRESS peer review of electronic search strategies: 2015 guideline statement","volume":"75","author":"McGowan","year":"2016","unstructured":"McGowan J,\nSampson M,\nSalzwedel DM,\nCogo E,\nFoerster V,\nLefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40-6. DOI: 10.1016\/j.jclinepi.2016.01.021"},{"key":"i2168-9709-16-3-150-b10","series-title":"Syst Rev","first-page":"210","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","unstructured":"Ouzzani M,\nHammady H,\nFedorowicz Z,\nElmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev. 2016;5:210. DOI: 10.1186\/s13643-016-0384-4"},{"key":"i2168-9709-16-3-150-b11","article-title":"Study quality assessment tools [Internet]","author":"National Heart, Lung, and Blood Institute","year":"2021","unstructured":"National Heart, Lung, and Blood Institute. Study quality assessment tools [Internet]. Bethesda: National Institutes of Health; 2021 [cited 2025 Jul 2]. Available from: https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools"},{"issue":"48","key":"i2168-9709-16-3-150-b12","series-title":"Health Technol Assess","first-page":"1","article-title":"Folate augmentation of treatment\u2014evaluation for depression (FolATED): randomized trial and economic evaluation","volume":"18","author":"Bedson","year":"2014","unstructured":"Bedson E,\nBell D,\nCarr D,\nCarter B,\nHughes D,\nJorgensen A, et al. Folate augmentation of treatment\u2014evaluation for depression (FolATED): randomized trial and economic evaluation. Health Technol Assess. 2014;18(48):vii-viii, 1-159. doi:10.3310\/hta18480"},{"issue":"1","key":"i2168-9709-16-3-150-b13","series-title":"Am J Psychiatry","first-page":"42","article-title":"Neurometabolic disorders: potentially treatable abnormalities in patients with treatment-refractory depression and suicidal behavior","volume":"174","author":"Pan","year":"2017","unstructured":"Pan LA,\nMartin P,\nZimmer T,\nSegreti AM,\nKassiff S,\nMcKain BW, et al. Neurometabolic disorders: potentially treatable abnormalities in patients with treatment-refractory depression and suicidal behavior. Am J Psychiatry. 2017;174(1):42-50. DOI: 10.1176\/appi.ajp.2016.15111500"},{"issue":"13","key":"i2168-9709-16-3-150-b14","series-title":"Psychol Med","article-title":"Metabolomic disorders: confirmed presence of potentially treatable abnormalities in patients with treatment-refractory depression and suicidal behavior","volume":"53","author":"Pan","year":"2023","unstructured":"Pan LA,\nSegreti AM,\nWrobleski J,\nShaw A,\nHyland K,\nHughes M, et al. Metabolomic disorders: confirmed presence of potentially treatable abnormalities in patients with treatment-refractory depression and suicidal behavior. Psychol Med. 2023;53(13):6046-54. DOI: 10.1017\/S0033291722003233"},{"issue":"11","key":"i2168-9709-16-3-150-b15","series-title":"JAMA Psychiatry","article-title":"Association between folic acid prescription fills and suicide attempts and intentional self-harm among privately insured US adults","volume":"79","author":"Gibbons","year":"2022","unstructured":"Gibbons RD,\nHur K,\nLavigne JE,\nMann JJ. Association between folic acid prescription fills and suicide attempts and intentional self-harm among privately insured US adults. JAMA Psychiatry. 2022;79(11):1118-23. DOI: 10.1001\/jamapsychiatry.2022.2990"},{"issue":"5","key":"i2168-9709-16-3-150-b16","series-title":"BJPsych Open","first-page":"e159","article-title":"Folic acid prescription and suicide attempt prevention: effect of past suicidal behaviour, psychiatric diagnosis and psychotropic medication","volume":"9","author":"Mann","year":"2023","unstructured":"Mann JJ,\nHur K,\nLavigne JE,\nGibbons RD. Folic acid prescription and suicide attempt prevention: effect of past suicidal behaviour, psychiatric diagnosis and psychotropic medication. BJPsych Open. 2023;9(5):e159. DOI: 10.1192\/bjo.2023.549"},{"key":"i2168-9709-16-3-150-b17","article-title":"Mini-international neuropsychiatric interview, English version 5.0.0 (DSM-IV)","author":"Sheehan","year":"2006","unstructured":"Sheehan DV,\nJanavs J, et al. Mini-international neuropsychiatric interview, English version 5.0.0 (DSM-IV). Tampa, FL: University of South Florida; 2006."},{"key":"i2168-9709-16-3-150-b18","article-title":"Suicidal ideation questionnaire (SIQ) professional manual","author":"Reynolds","year":"1987","unstructured":"Reynolds WM. Suicidal ideation questionnaire (SIQ) professional manual. Assessment Resources; 1987."},{"issue":"5","key":"i2168-9709-16-3-150-b19","series-title":"JAMA","article-title":"US Preventive Services Task Force. Folic acid supplementation to prevent neural tube defects: US Preventive Services Task Force reaffirmation recommendation statement","volume":"330","author":"Barry","year":"2023","unstructured":"Barry MJ,\nNicholson WK,\nSilverstein M,\nChelmow D,\nCoker TR,\nDavis EM, et al.; US Preventive Services Task Force. Folic acid supplementation to prevent neural tube defects: US Preventive Services Task Force reaffirmation recommendation statement. JAMA. 2023;330(5):454-9. DOI: 10.1001\/jama.2023.1287637526713"},{"issue":"44","key":"i2168-9709-16-3-150-b20","series-title":"Federal Register","article-title":"Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid; final rule","volume":"61","author":"U.S. Food and Drug Administration","year":"1996","unstructured":"U.S. Food and Drug Administration. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid; final rule. Federal Register. 1996;61(44):8781-97."},{"key":"i2168-9709-16-3-150-b21","series-title":"Front Public Health","first-page":"550753","article-title":"Association between folate and health outcomes: an umbrella review of meta-analyses","volume":"8","author":"Bo","year":"2020","unstructured":"Bo Y,\nZhu Y,\nTao Y, et al. Association between folate and health outcomes: an umbrella review of meta-analyses. Front Public Health. 2020;8:550753. DOI: 10.3389\/fpubh.2020.550753"},{"issue":"3","key":"i2168-9709-16-3-150-b22","series-title":"Am J Psychiatry","article-title":"Folate, vitamin B12, and homocysteine in major depressive disorder","volume":"154","author":"Fava","year":"1997","unstructured":"Fava M,\nBorus JS,\nAlpert JE, et al. Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatry. 1997;154(3):426-8. DOI: 10.1176\/ajp.154.3.4269054796"},{"issue":"8","key":"i2168-9709-16-3-150-b23","series-title":"J Clin Psychiatry","article-title":"Serum folate, vitamin B12, and homocysteine in major depressive disorder, part 1: predictors of clinical response in fluoxetine-resistant depression","volume":"65","author":"Papakostas","year":"2004","unstructured":"Papakostas GI,\nPetersen T,\nMischoulon D,\nRyan JL,\nNierenberg AA,\nBottiglieri T, et al. Serum folate, vitamin B12, and homocysteine in major depressive disorder, part 1: predictors of clinical response in fluoxetine-resistant depression. J Clin Psychiatry. 2004;65(8):1090-5. DOI: 10.4088\/JCP.v65n0810"},{"issue":"8","key":"i2168-9709-16-3-150-b24","series-title":"J Clin Psychiatry","article-title":"Serum folate, vitamin B12, and homocysteine in major depressive disorder, part 2: predictors of relapse during the continuation phase of pharmacotherapy","volume":"65","author":"Papakostas","year":"2004","unstructured":"Papakostas GI,\nPetersen T,\nMischoulon D,\nGreen CH,\nNierenberg AA,\nBottigleri T, et al. Serum folate, vitamin B12, and homocysteine in major depressive disorder, part 2: predictors of relapse during the continuation phase of pharmacotherapy. J Clin Psychiatry. 2004;65(8):1096-8. DOI: 10.4088\/JCP.v65n0811"},{"issue":"12","key":"i2168-9709-16-3-150-b25","series-title":"Am J Psychiatry","article-title":"L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials","volume":"169","author":"Papakostas","year":"2012","unstructured":"Papakostas GI,\nShelton RC,\nZajecka JM,\nEtemad B,\nRickels K,\nClaim A, et al. L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. Am J Psychiatry. 2012;169(12):1267-74. DOI: 10.1176\/appi.ajp.2012.11071114"},{"key":"i2168-9709-16-3-150-b26","article-title":"Guidance for industry: suicidal ideation and behavior\u2014prospective assessment of occurrence in clinical trials [Internet]","author":"US Food and Drug Administration, Center for Drug Evaluation and Research","year":"2012","unstructured":"US Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for industry: suicidal ideation and behavior\u2014prospective assessment of occurrence in clinical trials [Internet]. Silver Spring, MD: FDA; 2012 [2025 Jul 2]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/guidance-industry-suicidal-ideation-and-behavior-prospective-assessment-occurrence-clinical-trials"},{"issue":"4","key":"i2168-9709-16-3-150-b27","series-title":"Arch Suicide Res","first-page":"287","article-title":"Predictive validity of the MINI suicidal scale for self-harm in acute psychiatry: a prospective study of the first year after discharge","volume":"16","author":"Roaldset","year":"2012","unstructured":"Roaldset JO,\nLinaker OM,\nBj\u00f8rkly S. Predictive validity of the MINI suicidal scale for self-harm in acute psychiatry: a prospective study of the first year after discharge. Arch Suicide Res. 2012;16(4):287-302. DOI: 10.1080\/13811118.2013.722052"},{"issue":"4","key":"i2168-9709-16-3-150-b28","series-title":"Evid Based Ment Health","article-title":"Risk factors for suicide in adults: systematic review and meta-analysis of psychological autopsy studies","volume":"25","author":"Favril","year":"2022","unstructured":"Favril L,\nYu R,\nUyar A,\nSharpe M,\nFazel S. Risk factors for suicide in adults: systematic review and meta-analysis of psychological autopsy studies. Evid Based Ment Health. 2022;25(4):148-55. doi:10.1136\/ebmental-2022-300549"},{"issue":"6","key":"i2168-9709-16-3-150-b29","series-title":"Aust N Z J Psychiatry","article-title":"Suicide mortality after a nonfatal suicide attempt: a systematic review and meta-analysis","volume":"56","author":"Demesmaeker","year":"2022","unstructured":"Demesmaeker A,\nChazard E,\nHoang A,\nVaiva G,\nAmad A. Suicide mortality after a nonfatal suicide attempt: a systematic review and meta-analysis. Aust N Z J Psychiatry. 2022;56(6):603-16. DOI: 10.1177\/00048674211043455"},{"issue":"1","key":"i2168-9709-16-3-150-b30","series-title":"Arch Gen Psychiatry","first-page":"82","article-title":"International Suicide Prevention Trial Study Group. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT)","volume":"60","author":"Meltzer","year":"2003","unstructured":"Meltzer HY,\nAlphs L,\nGreen AI,\nAltamura AC,\nAnand R,\nBertoldi A, et al.; International Suicide Prevention Trial Study Group. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry. 2003;60(1):82-91. DOI: 10.1001\/archpsyc.60.1.82"},{"issue":"2","key":"i2168-9709-16-3-150-b31","series-title":"Focus (Am Psychiatr Publ)","first-page":"197","article-title":"Pharmacological and somatic treatment effects on suicide in adults: a systematic review and meta-analysis","volume":"21","author":"Wilkinson","year":"2023","unstructured":"Wilkinson ST,\nTrujillo Diaz D,\nRupp ZW,\nKidambi A,\nRamirez KL,\nFlores JM, et al. Pharmacological and somatic treatment effects on suicide in adults: a systematic review and meta-analysis. Focus (Am Psychiatr Publ). 2023;21(2):197-208. DOI: 10.1176\/appi.focus.23021006"},{"key":"i2168-9709-16-3-150-b32","article-title":"Prepregnancy Counseling","author":"American College of Obstetricians and Gynecologists","year":"2019","unstructured":"American College of Obstetricians and Gynecologists. Prepregnancy Counseling. Committee Opinion No. 762 [Internet] Washington, DC: ACOG; 2019 [cited 2025 Jun 16]. Available from: https:\/\/www.acog.org\/clinical\/clinical-guidance\/committee-opinion\/articles\/2019\/01\/prepregnancy-counseling"},{"issue":"9","key":"i2168-9709-16-3-150-b33","series-title":"Can J Psychiatry","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 update on clinical guidelines for management of major depressive disorder in adults","volume":"69","author":"Lam","year":"2024","unstructured":"Lam RW,\nKennedy SH,\nAdams C,\nBahji A,\nBeaulieu S,\nBhat V,et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 update on clinical guidelines for management of major depressive disorder in adults. Can J Psychiatry. 2024;69(9):641-87. DOI: 10.1177\/07067437241245384"}],"container-title":["Mental Health Clinician"],"original-title":[],"link":[{"URL":"https:\/\/mhc.kglmeridian.com\/view\/journals\/mhcl\/16\/3\/article-p150.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/mhc.kglmeridian.com\/downloadpdf\/journals\/mhcl\/16\/3\/article-p150.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/mhc.kglmeridian.com\/downloadpdf\/journals\/mhcl\/16\/3\/article-p150.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:31:29Z","timestamp":1780450289000},"score":1,"resource":{"primary":{"URL":"https:\/\/mhc.kglmeridian.com\/view\/journals\/mhcl\/16\/3\/article-p150.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":66,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.9740\/mhc.2026.06.150","relation":{},"ISSN":["2168-9709"],"issn-type":[{"value":"2168-9709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}